Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Hematol Oncol ; 4: 51, 2011 Dec 20.
Artículo en Inglés | MEDLINE | ID: mdl-22185092

RESUMEN

Although the majority of published cases of lead poisoning come from occupational exposures, some traditional remedies may also contain toxic amounts of lead. Ayurveda is a system of traditional medicine that is native to India and is used in many parts of world as an alternative to standard treatment regimens. Here, we report the case of a 58-year-old woman who presented with abdominal pain, anemia, liver function abnormalities, and an elevated blood lead level. The patient was found to have been taking the Ayurvedic medicine Jambrulin prior to presentation. Chemical analysis of the medication showed high levels of lead. Following treatment with an oral chelating agent, the patient's symptoms resolved and laboratory abnormalities normalized. This case highlights the need for increased awareness that some Ayurvedic medicines may contain potentially harmful levels of heavy metals and people who use them are at risk of developing associated toxicities.


Asunto(s)
Intoxicación por Plomo/etiología , Preparaciones de Plantas/efectos adversos , Quelantes/uso terapéutico , Contaminación de Medicamentos , Femenino , Humanos , Intoxicación por Plomo/diagnóstico , Intoxicación por Plomo/tratamiento farmacológico , Intoxicación por Plomo/patología , Medicina Ayurvédica , Persona de Mediana Edad , Preparaciones de Plantas/química , Succímero/uso terapéutico
2.
Am J Kidney Dis ; 52(3): 587-90, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18534729

RESUMEN

Deferasirox is a new iron chelator approved recently for chelation therapy in iron-overloaded patients. It is considered safe and efficacious in most patients, but has not been tested formally in patients with end-stage renal disease. We report a case of a patient with end-stage renal disease secondary to sickle cell nephropathy who developed recurrent symptomatic hypocalcemia while on therapy and later reexposure with this medication for iron overload from long-term blood transfusions. This is the first case report of this complication with deferasirox therapy in a patient with end-stage renal disease.


Asunto(s)
Benzoatos/efectos adversos , Hipocalcemia/inducido químicamente , Quelantes del Hierro/efectos adversos , Sobrecarga de Hierro/tratamiento farmacológico , Diálisis Peritoneal/efectos adversos , Triazoles/efectos adversos , Adulto , Anemia de Células Falciformes/complicaciones , Anemia de Células Falciformes/terapia , Benzoatos/uso terapéutico , Deferasirox , Eritropoyetina/uso terapéutico , Femenino , Humanos , Hipertensión/complicaciones , Quelantes del Hierro/uso terapéutico , Sobrecarga de Hierro/etiología , Fallo Renal Crónico/etiología , Fallo Renal Crónico/terapia , Reacción a la Transfusión , Triazoles/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...